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4. Abstract 
 
Nanomaterials possess unique properties due to their particular surface chemistry, 
topography and roughness. These peculiarities can affect the type, concentration and 
bioactivity of proteins adsorbed, which may or not inhibit subsequent cellular 
adhesion and growth. Among all the nanomaterials, carbon allotropes in the last 
decades have achieved success thanks to their biocompatible behavior. In particular 
DLC thin films have been used as coating materials for several biomedical implants 
devices. In this work we have deeply characterized DLC coated coronary stents  
surface (XPS, AFM, FESEM) and bulk (TEM/EELS, Raman, EDX) properties in 
order to understand tissue growth on nanomaterials. In vivo studies, conducted on 24 
pigs, have shown a complete endothelisation after 7 days, with no fibrin mesh and 
only rare monocytes scattered on the endothelial layer, while 30 and 180 days tests 
have shown a reduced inflammatory activation and a complete stabilization of the 
vessel healing and a minimal neointimal proliferation. Therefore, we can state that the 
DLC coating tested here appeared to be a promising material for rapid endothelisation 
of intravascular stent devices. 
 
 
5. Keywords 
Diamond-like carbon film, Coronary stent, Surface analysis, Endothelisation, 
Histology, Cobalt-Chromium alloy. 
 
 
6. Introduction 
 
Every time a foreign body comes into contact with a human corpus, the response of 
the immune defense system is proportional to the alarm bell that has been activated. 
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Nevertheless it is sometimes necessary to include foreign materials inside human 
organs and tissues in order to solve health problems. This happens for instance when 
we are dealing with cardiovascular diseases, which are tackled mainly by implanting 
valves and/or coronary stents. For this reason, after having chosen the best shape and 
size, in order to be less invasive as possible, it is necessary to focus onto which kind 
of material can be the best solution to mimic body tissue and to prevent inflammations 
and eventually be rejected. Literature [1,2] shows that such materials have to fulfill 
several requirements, such as possess appropriate mechanical properties and surface 
characteristics, excellent haemocompatibility and good biocompatibility. Hence, the 
success lies in choosing the material that possesses most of the sought properties. 
Carbon based materials have been considered, in the last decades, as one of the most 
biocompatible compounds and they have been used as coating materials for bare 
metallic structures, since they are chemically inert and they can reduce metal ion 
release from the inner substrates. Among all the carbon allotropes, diamond-like 
carbon (DLC) has been selected to grow films mainly for its hardness, low friction 
coefficient, low wear rate, strong adhesion to substrate and smooth surface finishing 
[3,4]. These properties make it ideal as coating for cardiovascular (heart valves and 
peripheral stents), orthopaedic, and dental applications [5-7]. DLC remarkable 
properties derive from its amorphous atomic structure, which depends on its sp2/sp3 
ratio that is strongly correlated with the deposition technique used. Such techniques  
fall into two broad categories, depending on whether the process is primarily chemical 
or physical. For the first category chemical vapour deposition (CVD) is the most 
utilised, while for the second one the possibilities are multiples: including ion beam 
deposition, filtered cathodic vacuum arc deposition, DC and RF sputtering, pulsed 
laser deposition, and plasma immersion ion implantation [8,9]. Moreover deposition 
at low temperature allow to grow DLC thin films on high temperature-sensitive 
substrates like polymers and metals with low melting point [10]. In order to be sure 
about DLC biocompatibility, several studies have been accomplished on various form 
of these carbon films: from blood-compatibility [11,12] to cell activity and cytotoxic 
effects surveys with several cell culture lines [13,14]. A low degree of platelets 
spread-out on DLC coated medical devices has been associated to a low degree of 
roughness and a hydrophobic behaviour of the surface [15]. Furthermore it has been 
proved that DLC thin films can prolong the clotting time and suppress the platelets 
and complement convertase activation, if compared to references as polymer 
substrates or Si wafers [16]. Another important aspect is the non activation of 
inflammatory signals, that can produce pathological responses to the implants like the 
formation of blood clots, as reported by several authors [17,18]. Previous 
investigations of DLC as a biomaterial have focused mainly on the biological 
performance of DLC coatings by means of cell cultures or cytotoxicity studies 
[19,20], without a detailed understanding of the composition and structural effects of 
the coating for specific biomedical applications. Recently the attention has been 
focused mainly on the characterization of the DLC surface in order to propose an 
explanation about the relationship between DLC surface physico-chemical properties 
and biological response [21, 22]. 
In this outlook our scope is to provide directly a complete characterization of this 
DLC coating (iCarbofilm
TM
), deposited on cobalt chromium alloy coronary stents. For 
this reason, surface and bulk physical properties and pro-healing effect, based on two 
biological response parameters, rapid endothelisation and long term inflammatory 
responses, will be investigated.  
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7. Materials and Methods 
 
7.1 Materials 
Twenty six Avantgarde™ stents manufactured by CID S.p.A. (Saluggia, VC, Italy) 
were prepared to both assess the physical properties of the carbon coated stent 
surfaces and the pro-healing effect by means of implant in porcine native coronary 
arteries. Avantgarde stent is a Cobalt-Chromium (L605) alloy stent coated with a thin 
film (< 0.3 µm) of high density pure carbon. All Avantgarde stents, before coating 
process, were mirror-like polished and cleaned. The carbon film (iCarbofilm
TM
) was 
deposited on the stent surface by means of a Physical Vapor Deposition (PVD) 
technique at low-temperature (T < 100 °C) obtaining a very high adhesion force to the 
alloy substrate (> 70 MPa), measured with the pulling test (ASTM D4541 and 
ISO4624). Two Avantgarde stents were dedicated to physical examinations while the 
remaining 24 were implanted in porcine coronary arteries for in vivo assessment of 
endothelization at 7 days and tissue inflammatory response at 30 and 180 days. 
Avantgarde stents were compared with 24 clinical grade Cobalt-Chromium stents 
(Multi-Link Vision – Abbott Vascular Laboratories –USA) used as control group. 
 
7.2 Coating characterization 
 
7.2.1 X-ray Photoelectron Spectroscopy (XPS) 
A Thermo Scientific Sigma Probe X-ray Photoelectron Spectroscopy (XPS) device 
equipped with a monochromatic Al X-ray source (14.866 keV energy, 15 kV voltage 
and 1 mA anode current), has been used in order to investigate samples surface 
chemical composition and carbon allotrope state. A spot size of 100 m has been used 
in order to collect the signal only from the stent structure. Different Pass Energy (PE) 
values have been used for the various types of spectra acquisition: 300 eV for survey 
spectra, 50 eV for C 1s peak, 100 eV for the valence band region and 20 eV for the O 
1s peak.  
 
7.2.2 Field Emission Scanning Electron Microscope (FESEM) combined with Energy-
Dispersive X-ray spectroscopy (EDX) 
The ZEISS SUPRA 40 Field Emission Scanning Electron Microscope (FESEM) has 
been used to analyse sample surface to check roughness and morphology. No need for 
metal sputter-coating since our films are  sufficiently conductive. An OXFORD INCA 
ENERGY 450 EDX, equipped with a Liquid-nitrogen cooled Si(Li) detector (with 
guaranteed resolution of 133 eV at MnKα, 70 eV at FKα and 66 eV at CKα), has been 
used to obtain information regarding film chemical composition.  
 
7.2.3 Raman Spectroscopy 
The Raman spectra were recorded using a Renishaw inVia confocal Raman 
spectrometer coupled to a Leica microscope with 50× objective in backscattering 
geometry. The source wavelengths have been generated with an Argon-Krypton laser 
and used with a holographic notch filter with a grating of 1800 lines per millimeter for 
514 nm line and 2400 lines per millimeter for the 458 nm one. The backscattered 
Raman signals were collected on a thermoelectrically cooled (-60 °C) CCD detector. 
The scattering spectra were recorded in the range of 0-3500 cm
-1
, in one acquisition, 
30 s accumulations, and 0.7 mW at the sample. 
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7.2.4 Atomic Force Microscopy (AFM) 
Film surface morphology has been investigated in ambient atmosphere with a Digital 
Instruments NanoScope IIIa Atomic Force Microscope (AFM) operating in tapping 
mode using NanoScope Software 6.1 version. 
 
7.2.5 Transmission Electron Microscopy (TEM) combined with Electron Energy Loss 
Spectroscopy (EELS) 
Experiments were performed on a Philips CM200 TEM (LaB6 filament, 200 kV 
accelerating voltage) fitted with a Gatan Imaging Filter (GIF 2000 with a 1k×1k 
Charge-Coupled-Device), which allows for Electron Energy Loss Spectroscopy. A 
Carbon film portion has been detached mechanically from each sample by lapping the 
metal part by means of fine grit sandpaper.  
 
7.3 In vivo studies 
The tests were conducted on 24 pigs. All animals were randomly implanted with one 
Avantgarde and one control stent (right coronary artery and left descending anterior 
coronary artery). They were anesthetised and treated with antibiotics, then heparinised 
150 (UI/Kg) by intra-arterial route (ACT > 300 s). An arterial access was made in the 
common right carotid artery by means of a 7 F introducer. A Judkins or Amplaz type 
guide catheter was inserted through the introducer by means of a J guidewire, size 
0.035”. The coronary ostium was reached with injection of contrast media. The 
investigational devices were implanted through a 6 F guide catheter over a 0.014” 
guidewire. The operation was monitored by angiography, the device was driven until 
the implantation site was reached then it was expanded by appropriate pressure 
(vessel/device diameter ratio of 1:1.1) until it was well apposed to the vessel wall. The 
antiplatelet treatment was limited to aspirin from two days before the procedure to the 
seventh post-procedural day then suspended. No supplementary antiplatelet drugs 
(ticlopidine or clopidogrel) were administered. At the end of the prescribed follow-up, 
all animals underwent a further angiographic examination in order to assess the vessel 
patency. The animals were anesthetised with intramuscular injections of 2 mg/Kg di 
Ketamine and 2 mg/Kg of Xylazine and by inhaling Isofluoran 1%. A 7 F introducer 
was positioned in the left carotid artery and a follow-up angiography was carried out 
on the implanted coronaries using a similar method as described above. The animals 
received 14.000 IU of intravenously administered heparin. The animals were then 
euthanised by an intravenous injection of barbiturate (60 mg/kg) through the jugular 
access, following the “AVMA guidelines on Euthanasia (June 2007)”. After the 
explant, the heart was submitted to X-ray analysis to confirm stent location, following 
which the coronary trees were perfused with heparinised physiological solution. When 
the perfused liquid looked free from haematic traces, the coronaries were fixed with a 
solution of formaldehyde at 4% at 150 mmHg pressure. The coronary vessels were 
then carefully dissected from the epicardial surface, preserving the artery size and 
shape. Then the samples were formalin post-fixed. The stents explanted at 7 days 
were processed for scanning electron microscopy (SEM) to assess endothelisation. 
Stent segments for SEM analysis were longitudinally cut, critical point dried and, 
before gold coating, pictures were taken of each half-stent by a stereo microscope at 
high magnification. After the gold coating the stent segments were analysed by 
scanning electron microscopy at 35x and 250x magnification (or higher if necessary) 
to observe the surface of the stent. Endothelization was calculated from the 
stereoscopic images measuring the non-endothelised strut surfaces over the total 
extent of strut surfaces. The stented coronary segments at 30 and 180 days were 
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processed for methyl-methacrylate embedding. A representative number of 5 μm 
sections were cut perpendicularly to the long axis of the vessel by a precision 
microtome, at the proximal, mid and distal stent level. Histological sections were 
stained with Haematoxylin and Eosin (HE) and Movat Pentachromic. 
Photomicrographs were taken for each segment of interest, in order to process for 
histologic and histomorphometric analysis. Endothelisation percent and 
histomorphometric variables were measured and analysed by Image-Pro Plus software 
(Media Cybernetics Inc. Bethesda, MD, USA). 
 
8. Results and discussion 
 
8.1 Stent analysis pre-implantation 
 
In order to understand how the growth parameters affected the film morphology and 
its biocompatible behaviour, first of all we have conducted a complete surface and 
bulk characterization of our film [23]. We performed XPS analysis on two different 
locations for both inner and outer surfaces of the stents. Survey spectra (see fig. 1) 
show two main photo-electronic peaks at 531 eV (O 1s) and 285 eV (C 1s) and Auger 
peaks at 1000 eV (O KLL). We detected also some small peaks due to surface 
contamination (N, Fe, Na, Si and Cl). Relative atomic concentration has been 
evaluated after subtracting the background with a Shirley function [24] obtaining ~ 
15-20% for O 1s and less than 3% for the contaminants. C 1s high resolution spectra 
(see fig. 2) have been decomposed, using three Voigt functions for each peak, in order 
to evaluate sp2/sp3 ratio. After an exhaustive research in literature [25-28] we 
attributed the three peaks to the following Carbon bonds: 284.2-284.5 eV to sp2 
component; 285.2-285.6 eV to sp3 bonded carbon and 286.1-288.1 eV to chemical 
shifts due to C-O bonds (C-O-C, C=O,...).  
The sp3 amount is roughly constant (from 35.4% to 39.7%) in all investigated 
locations. This can be attributed to a chemically homogeneous surface characterised 
by regions which do not differ very much one to each others.  
It is interesting to note that in the case of amorphous carbon materials that have both 
sp2 and sp3 atoms, the study of the C 1s spectrum can be supported focusing the 
attention onto another region of the XPS spectrum: the valence band (VB) [29,30]. 
McFeely et al. [31] have conducted an accurate study to this purpose analyzing 
diamond, graphite and amorphous carbon valence bands. It is possible to distinguish 
three main features: a moderately broad and intense peak in the range between 15 and 
21 eV (peak I), a less intense peak between 10 and 15 eV (peak II) and a broad and 
less defined structure extended from 10 to 13 eV to the cut-off energy (peak III). The 
valence bands arise predominantly from 2s and 2p atomic states. Peak I intensity is 
greater than peak III one mainly because of the large difference in the photoemission 
cross-section ratio as (2s)/ (2p)=13 [32]. Since peak II is practically absent in 
graphite and amorphous carbon VB spectra, we conclude that it is due to sp3 hybrids 
bonds. In our stent valence band spectrum (see fig. 2 inset) the three peaks (I, II and 
III) are not so evident, and the overall spectrum is similar to the glassy carbon valance 
bands reported by McFeely [31]. The presence of the O 2s peak at 26 eV makes the 
decomposition of the signal  quite unreliable, because of the overlap between it and 
peak I. Hence, an estimate of sp2/sp3 ratio from this spectrum will lead to a very large 
error bar.  
To further test our coatings surfaces, field emission scanning electron microscope 
(FESEM) combined with energy-dispersive X-ray spectroscopy (EDX) was used to 
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detect the surface micro morphology (see fig. 3) and bulk chemical composition [33]. 
We can observe micro and nano-structures: the first are “cauliflower-like” and their 
average dimensions vary accordingly to the area tested (from 20 to 60 nm inside and 
from 50 to 120 nm outside), while the latter appear to be constant (around 6 nm) 
independently from side and zone. Cauliflower-like features dimensions are bigger on 
the outer side of the stent. EDX spectra have shown several chemical elements apart 
from C and O (Co, Fe, Ni, W and Cr) which correspond to the L605 alloy chemical 
composition. FESEM results have been confirmed by AFM analysis (see fig. 4), 
which have shown an average roughness (RMS) which goes from (2.7  0.2) nm for 
the bigger scan range (3.3 × 3.3) m
2
 to (1.6  0.4) nm for the smallest one (370 × 
370) nm
2 
[34]. To investigate stent coating morphology and property at the bulk level 
we performed two additional analysis: Raman spectroscopy and Transmission 
Electron Microscopy (TEM), this last combined with Electron Energy Loss 
Spectroscopy (EELS). The first is a well known technique providing information 
about carbon allotropes kind and crystalline structure dimensions [35]. Using the 514 
nm laser line excitation, we evaluated Id/Ig ratio for each stent zone (inside and 
outside). This ratio is correlated with the grain size thanks to the Tuinstra-Koening 
formula: Id/Ig = C( ) La
-1 
[36], where C( ) is a constant depending on the laser 
wavelength [37] and La is the grain size in nm. In table 1 we have reported the values 
obtained using that relationship. They show the presence of grains having smaller 
dimension on the inside surfaces respect to outside ones. In order to confirm these 
results we performed Raman analysis with a 458 nm laser line, obtaining Id/Ig values 
of 1.33 and 1.29 (inside and outside respectively) confirming a higher Id/Ig ratio for 
the inner zone. TEM measurements confirm that the “cauliflower” structure is present 
also inside the film (see fig. 5). In the same areas we have also performed EELS 
analysis, from which we calculated the sp2/sp3 ratio thanks to the 3-Gaussian method 
[38], obtaining an amount of sp3 bonds equals to 41%. 
On the basis of the above results and discussion we conclude that the stent coating has 
a homogeneous, both morphologically and chemically speaking, low roughness 
surface with very small grains (estimated size from 3 to 6 nm) and possesses a high 
amount of sp3 bonds (41% from bulk analysis). 
 
8.2 Analysis of explanted stents 
 
8.2.1.  Endothelization 
 
The SEM examination of the half-stent surfaces after 7 days of implant revealed no 
significant presence of thrombotic milieu in both stent groups. The histological 
analysis outlined a good endothelial coverage over the strut surfaces with a carpet of 
cobblestone like confluent cells. The percent of endothelium coverage measured by 
histomorphometric assessment was 98% in Avantgarde vs. 65% in Vision (see fig. 6). 
It is remarkable to observe that in Vision stents the endothelial cells growth was quite 
inhomogeneous and the lack of early endothelization was reported even in presence of 
well apposed struts where cell colonization is usually observed. On the contrary in 
Avantgarde stents endothelial cells also covered not completely well apposed struts. 
The stent surface of the control group at high magnification (see fig. 7) showed a 
diffuse fibrin mesh entrapping red blood cells, monocytes, focal giant cells and small 
luminal adherent thrombi. In the Avantgarde group no fibrin mesh was observed and 
only rare monocytes were scattered on the endothelial layer; thrombi were absent and 
the endothelium was flat and confluent. The endothelial cell stent coverage showed to 
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be in continuity with the native vascular endothelium. This outcome in an in vivo 
model is in line with the observations reported in Ma et al. [22] and in Fedel et al. 
[39,40] regarding the albumin:fibrinogen selective adsorbtion that was reported for 
DLC coatings, especially when rich in sp3 bonds. Moreover Fedel [39] observed that 
DLC coating showed a competitive and stable albumin passivation against fibrinogen. 
This condition induces a very limited adhesion and activation of circulating platelets 
and in consequence no trigger of thrombotic clots as confirmed in our experiment. 
 
8.2.2 Inflammatory responses 
 
Ten Avantgarde and 10 Vision stents were electively explanted at 30 days of follow-
up. Stent expansion reached nominal diameter for both devices. The lumen of 
coronary arteries implanted with Avantgarde stents was lined by a smooth, continuous 
layer of endothelial cells. Histological sections (see fig. 8-A) showed a slight, uniform 
neointimal growth, free from significant inflammation and mainly composed by 
smooth muscle cells in a compact proteoglycan matrix without blood clots. The elastic 
lamina appears to be distended and compressed mainly in correspondence with the 
struts but fully intact. 
The Vision stents histological samples at 30 days showed the presence of a continuous 
endothelial coating. A moderate neointimal proliferation can be seen, irregularly 
distributed and probably related to mechanical action (see fig. 8-B) caused by 
asymmetric distribution of the struts during stent expansion. 
Ten animals were electively sacrificed after 180 days follow-up. These animals had 
been subjected to double implants for a total of 10 Avantgarde and 10 Vision stents. 
All the animals were in good clinical condition at the time of explants and 
angiography confirmed all stents implanted were non-obstructive. The histological 
images of coronary arteries implanted with Avantgarde showed stabilized repair 
processes. In fact, the peak inflammatory response is generally found at 30 days after 
implant, whilst at longer follow-ups a reduction in tissue reaction can be observed. 
The neointimal layer was regular and thin (see fig. 8-C). The few smooth muscle cells 
present are embedded in a fibrous connective tissue which appears to be well-
organized in layers. There is no evidence of granulomas and chronic inflammatory 
cells. Both elastic laminae were intact, though in a number of samples they were 
slightly compressed in correspondence with the stent struts. 
With reference to Vision, the neointimal layer appeared thicker and slightly 
asymmetrical, with occasional macrophages around stent struts (see fig. 8-D). The 
elastic laminae resulted intact in most of the investigated samples, with few 
exceptions where the internal elastic lamina was lacerated by some struts. 
Histomorphometric analysis showed in both cases a mild neointimal growth and 
restenotic response. Nonetheless in the Avantgarde group all measured parameters 
were lower at 30 days. Such early difference between Avantgarde and Vision 
increased from 30 to 180 days reaching statistical significance for the neointimal 
thickness and area values (see table 2). This is an evidence confirming the minimal 
inflammatory elicitation induced by the DLC coating of Avantgarde stent. The 
distinct in vivo inflammatory reaction induced by the two devices and leading to 
slightly different proliferative responses can be explained by the surface polishing and 
DLC coating properties. In fact this particular carbon film appeared to be composed 
by homogenous small nanostructures and is applied in an extremely thin layer. All 
these characteristics preserving the mirror polished surface of the Avantgarde stent 
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reduced platelets activation and in turn the adhesion of inflammatory cells and the 
proliferative activation of the smooth muscle cells. 
 
 
9. Conclusions 
 
DLC films deposited by PVD on Co-Cr alloy stents were analyzed with respect to 
their surface morphology (AFM, FESEM), chemical state (XPS), bulk sp3 content 
(EELS), morphology (TEM) and composition (Raman and EDX). Biological tests 
were conducted after 7 days in order to verify rapid endothelisation, and after 30 and 
180 days to investigate inflammatory responses. Our results showed that iCarbofilm™ 
is rich in sp3 bonds (41%) and its nanostructured surface is morphologically and 
chemically speaking homogeneous, thanks also to its thinness, which preserves the 
metal substrate smooth surface. These characteristics, as mentioned in several papers 
[22,40], lead to a selective adsorption of proteins (albumin instead of fibrinogen) and 
to a very low platelets activation. From the above characteristics and from the cited 
results it was expected for this new DLC coating an extremely favourable 
haemocompatibility and a non-inflammatory behaviour. The results obtained from 
this study indeed confirmed this foresight, showing for DLC coated Co-Cr stents 
(Avantgarde) a more complete and homogeneous endothelization, without triggering 
of thrombotic clots thanks to the inhibition of fibrin deposits and platelet activation. 
On the other hand, the reduced inflammatory activation related to this coating led to a 
complete stabilization of the vessel healing within 30 days and a minimal neointimal 
proliferation at 180 days. 
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Figure 3 
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Figure 6 
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Figure 8 
 
 
 
13. Figure Captions and Tables 
 
 
Fig.1 XPS survey spectrum of one point on the inner side of the Avantgarde stent, showing two main 
photoelectronic peaks (C1s and O1s) and several smaller peaks (N1s, Si 2p and Si 2s) due to some 
surface contaminations. 
 
Fig.2 XPS C1s peak high resolution spectrum showing the deconvolution made with three Voigt 
functions, which give the contribution of the sp2, sp3 and C-O chemical shifts. DLC valence band 
spectrum has been reported in the inset, together with a diamond reference spectrum taken from [31], 
showing the absence of the diamond finger print peak at 13 eV (peak II).    
 
Fig.3 The FESEM images of the stent inner (A) and outer (B) side, showing the cauliflower structures 
due to the microstructures and the small round shapes due to the nanostructures   
 
Fig.4 AFM maps taken at two scan range, (3.3 × 3.3) m
2
 (A) and (370×370) nm
2 
(B). The first one 
shows the uniformity of the grains distribution, while the second one shows the bigger and smaller 
structures, as shown by FESEM  
 
Fig.5 TEM picture of a portion of the DLC film confirms that the “cauliflower” structure is present also 
inside the film  
 
Fig.6 (A) Avantgarde SEM stent image (35X) after 7 days of implantation in a pig coronary artery and 
metallization. The image shows a perfect total device endothelization (98%). (B) CoCr uncoated Vision 
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stent after 7 days of implantation in a pig coronary artery and metallization. Endothelium uncovered 
stent struts are visible along the whole structure (percentage of endothelization 65%). 
 
Fig.7 (A) Avantgarde stent SEM image (200X). Detail of the endothelial layer. Polygonal shaped 
endothelial cells are clearly recognizable. The cell layer is a continuum between native vessel tissue and 
new cells covering the metallic structure. Note: The visible layer detachments are due to the SEM 
technique. (B) CoCr uncoated Vision stent. It is clearly visible the fibrin net adherent to the metallic 
structures and vessel endothelium. Several leucocytes and examples of multinucleated giant cells are 
present. This type of cell tends to occupy the non-endothelized areas of the stent.  
 
Fig.8 Histological section MOVAT (20X magnification). (A) Avantgarde stent at 30 days. Right coronary 
artery. Thin and regular layer of neointimal tissue. (B) CoCr uncoated Vision stent at 30 days  Left 
descending artery. Neointimal growth was moderate but slightly asymmetrical. Endothelization appears 
complete and only few fibrin deposits around struts are detectable. (C) Avantgarde stent at 180 days. 
Right coronary artery. Neointimal tissue was minimal and no signs of inflammation or fibrin and blood 
clots are present. (D) CoCr uncoated Vision stent at 180 days. Left descending artery. Neointimal tissue 
has slightly increased and appeared asymmetrical and highly composed by extracellular matrix. Fibrin 
deposits have been reabsorbed and no inflammatory cells were detected.  
 
 
 
 
 
 
 Table 1: Raman Id/Ig ratios calculated for inside and outside scanned areas and grain sizes 
calculated via Tuinstra formula [36], with their relative errors ( ) 
 
Surface 
 
Id/Ig (Id/Ig) 
 
La (nm) (La)  (nm) 
inside 1.45 ± 0.04 3.00 ± 0.08 
outside 1.26 ± 0.15 3.5 ± 0.4 
  
 
 
Table 2: Histomorphometric analysis results for both stents at 30 and 180 days (n= number of 
histological sections; * Neointimal Area and Neointimal Thickness Avantgarde vs. Vision p<0.05) 
 30 days 180 days 
 n Avantgarde Vision n Avantgarde Vision 
Neointimal Area (mm
2
) 10 1.1  0.5 1.4  0.8 10 1.0 0.4* 1.5 0.4 
Neointimal Thickness 
(mm) 
10 0.14 0.09 0.18 0.11 10 0.10 0.05* 0.16 0.06 
Vessel Stenosis (%) 10 24  13 27  11 10 21 8 27 6 
 
